17 min listen
ASHP Advantage: Reverse to Go Forward: Monitoring and Cost Considerations for Reversing Neuromuscular Blockade
FromASHPOfficial
ASHP Advantage: Reverse to Go Forward: Monitoring and Cost Considerations for Reversing Neuromuscular Blockade
FromASHPOfficial
ratings:
Length:
33 minutes
Released:
Feb 15, 2022
Format:
Podcast episode
Description
Learn from experts in the field on key issues for safe neuromuscular blockade and reversal strategies. Topics include discussion of the current process of neuromuscular blockade (NMB) monitoring and reversal with a focus on the anesthesiologist perspective in the operating room. Cost considerations when monitoring and reversing NMB will also be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Released:
Feb 15, 2022
Format:
Podcast episode
Titles in the series (100)
From the Frontline of COVID-19: Managing Drug Excipient Toxicities in the wake of COVID-19: In the wake of drug shortages, patients with a high requirement for sedation coupled with an increase in the number of patients who have renal failure due to complications to COVID-19, pharmacists must be ever vigilant on managing patient’s mediatio... by ASHPOfficial